Alector, Inc.

Biotechnology company · South San Francisco, California, United States · Nasdaq: ALEC

Alector, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker ALEC. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2015.

Profile compiled from public records. Is this your company? Request a correction or update

Alector at a glance

Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2013
Stock listingNasdaq: ALEC
SEC industryBiological Products, (No Diagnostic Substances)
Employees (per SBIR records)25
SEC CIK1653087

What does Alector do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1.5 million in total (2015 to 2016). NIH funding came from the National Institute on Aging.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $32.3 million sold (2015).

Frequently asked questions about Alector

Where is Alector headquartered?

Alector, Inc. is headquartered in South San Francisco, California, United States.

What does Alector do?

Alector, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Alector a public company?

Yes. Alector, Inc. trades on Nasdaq under the ticker ALEC.

When was Alector founded?

The earliest incorporation on record for Alector, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.